Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease

OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) as well as the detection of anti-infliximab antibodies (ATIs) in patients with Crohn's disease (CD). METHOD: Forty patients with CD under treatment at a tertiary center in southeastern Brazil were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clinics (Sao Paulo)
Main Authors: Gomes, Luis Eduardo Miani, da Silva, Francesca Aparecida Ramos, Pascoal, Lívia Bitencourt, Ricci, Renato Lazarin, Nogueira, Guilherme, Camargo, Michel Gardere, de Lourdes Setsuko Ayrizono, Maria, Fagundes, João José, Leal, Raquel Franco
Formato: Artigo
Idioma:Inglês
Publicado em: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445154/
https://ncbi.nlm.nih.gov/pubmed/30994711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2019/e824
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados